Original articles

Identifying Qingkailing (清开灵) ingredients-dependent mesenchymal-epithelial transition factor-axiation “π” structuring module with angiogenesis and neurogenesis effects

  • Kunming CHENG ,
  • Jianan YUAN ,
  • Jun LIU ,
  • Shengpeng ZHANG ,
  • Qixiang XU ,
  • Yong XIE ,
  • Jingfeng ZHAO ,
  • Xiaoxu ZHANG ,
  • Xudong TANG ,
  • Yongqiu ZHENG ,
  • Zhong WANG
Expand
  • 1 Provincial Engineering Laboratory for Screening and Re-evaluation of Active Compounds of Herbal Medicines in Southern Anhui, Teaching and Research Section of Traditional Chinese Medicine, School of Pharmacy, Wannan Medical College, Wuhu 241000, China
    2 Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
    3 Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Department of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China
    4 Department of Gastroenterology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China

Received date: 2023-02-19

  Accepted date: 2023-05-22

  Online published: 2023-12-28

Supported by

National Major Scientific and Technological Special Project for “Significant New Drugs Development”: Clinical Value Prescription Discovery and Evaluation Technology Based on Modular Pharmacology(2017ZX09301059);Joint Innovation Project of China Academy of Chinese Medical Sciences: Study on the Mechanism of Action of Neuronal Regenerative Function Module Activated by Qingkailing Components(ZZ11-026);University Collaborative Innovation Project of Anhui: Creation of a Combined Animal Model of Coronary Heart Disease Based on the Theory of Xin'an Medicine(GXXT-2020-024);University Natural Science Research Project of Anhui Province :Molecular Mechanism of the Anti-hepatic Fibrosis Effect of Wickerwork Amide Based on the Regulation of Intercellular Communication by PTRF(2023AH051752)

Abstract

OBJECTIVE: To explore the functional role of the drug-dependent mesenchymal-epithelial transition (Met)-axiation "π" structural module of neurogenesis after processing by three components of Qingkailing injection in neurogenesis and angiogenesis in cerebral ischemia.

METHODS: We used a Glutathione S-transferase (GST)-pull down assay, isothermal titration calorimetry assay, and other related methods to identify the relationships among Met, inositol polyphosphate phosphatase like 1 (Inppl1), and death associated protein kinase 3 (Dapk3) in this allosteric module. The biological effects of the modules of neurons generation composed of Met, Inppl1, and Dapk3 were measured through Western blot, apoptosis analysis, and double immunofluorescence labeling.

RESULTS: The GST-pull down assay revealed that proline-serine-threonine rich domain of Met binds to the Src homology domain of Inppl1 to form a protein-protein complex; Dapk3 with a C-terminal domain interacts weakly with the protein kinase C domain of Met in the intracellular region. Thus, we obtained a “π” structuring module considered a neural regeneration module. The biological effects of angiogenesis and neurogenesis modules composed of Met, Inppl1, and Dapk3 were also verified.

CONCLUSION: The study suggested that understanding the functional modules that contribute to pharmaceutics might provide novel signatures that can be used as endpoints to define disease processes under stroke or cerebral ischemia conditions.

Cite this article

Kunming CHENG , Jianan YUAN , Jun LIU , Shengpeng ZHANG , Qixiang XU , Yong XIE , Jingfeng ZHAO , Xiaoxu ZHANG , Xudong TANG , Yongqiu ZHENG , Zhong WANG . Identifying Qingkailing (清开灵) ingredients-dependent mesenchymal-epithelial transition factor-axiation “π” structuring module with angiogenesis and neurogenesis effects[J]. Journal of Traditional Chinese Medicine, 2024 , 44(1) : 35 -43 . DOI: 10.19852/j.cnki.jtcm.2024.01.004

References

1. Beltrao P, Cagney G, Krogan NJ. Quantitative genetic interactions reveal biological modularity. Cell 2010; 141: 739-45.
2. Suthram S, Dudley JT, Chiang AP, Chen R, Hastie TJ, Butte AJ. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol 2010; 6: e1000662.
3. Lorenz DM, Jeng A, Deem MW. The emergence of modularity in biological systems. Phys Life Rev 2011; 8: 129-60.
4. Wang Z, Wang YY. Modular pharmacology: deciphering the interacting structural organization of the targeted networks. Drug Discov Today 2013; 18: 560-6.
5. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL. Hierarchical organization of modularity in metabolic networks. Science 2002; 297: 1551-5.
6. Wang Z, Liu J, Yu Y, Chen Y, Wang Y. Modular pharmacology: the next paradigm in drug discovery. Expert Opin Drug Discov 2012; 7: 667-77.
7. Horvath S, Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 2008; 4: e1000117.
8. Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480?687 adults. Circulation 2017; 135: 759-71.
9. Meng X, Chu G, Yang Z, et al. Metformin protects neurons against oxygen-glucose deprivation/reoxygenation-induced injury by down-regulating mad2b. Cell Physiol Biochem 2016; 40: 477-85.
10. Chelluboina B, Nalamolu KR, Mendez GG, et al. Mesenchymal stem cell treatment prevents post-stroke dysregulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases. Cell Physiol Biochem 2017; 44: 1360-69.
11. Liu J, Zhang ZJ, Zhou CX, et al. Outcome-dependent global similarity analysis of imbalanced core signaling pathways in ischemic mouse hippocampus. CNS Neurol Disord Drug Targets 2012; 11: 1070-82.
12. Li KN, Zhang YY, Yu YN, Wu HL, Wang Z. Met-controlled allosteric module of neural generation as a new therapeutic target in rodent brain ischemia. Chin J Integr Med 2021; 27: 896-904.
13. Lü C, Maharjan S, Wang Q, et al. A-lipoic acid promotes neurological recovery after ischemic stroke by activating the nrf2/ho-1 pathway to attenuate oxidative damage. Cell Physiol Biochem 2017; 43: 1273-87.
14. Yang K, Bai H, Ouyang Q, Lai L, Tang C. Finding multiple target optimal intervention in disease-related molecular network. Mol Syst Biol 2008; 4: 228.
15. Rognan D. Chemogenomic approaches to rational drug design. Br J Pharmacol 2007; 152: 38-52.
16. Hellerstein MK. Exploiting complexity and the robustness of network architecture for drug discovery. J Pharmacol Exp Ther 2008; 325: 1-9.
17. Tegner J, Yeung MK, Hasty J, Collins JJ. Reverse engineering gene networks: integrating genetic perturbations with dynamical modeling. Proc Natl Acad Sci U S A 2003; 100: 5944-9.
18. Kam TI, Park H, Gwon Y, et al. Fcγriib-ship2 axis links aβ to tau pathology by disrupting phosphoinositide metabolism in alzheimer's disease model. Elife 2016; 5: e18691.
19. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-4.
20. Koch A, Mancini A, El Bounkari O, Tamura T. The sh2-domian-containing inositol 5-phosphatase (ship)-2 binds to c-mett directly via tyrosine residue 1356 and involves hepatocyte growth factor (hgf)-induced lamellipodium formation, cell scattering and cell spreading. Oncogene 2005; 24: 3436-47.
21. Usui T, Okada M, Hara Y, Yamawaki H. Death-associated protein kinase 3 mediates vascular inflammation and development of hypertension in spontaneously hypertensive rats. Hypertension 2012; 60: 1031-9.
22. Rivas S, Marín A, Samtani S, González-Feliú E, Armisén R. Met signaling pathways, resistance mechanisms, and opportunities for target therapies. Int J Mol Sci 2022; 23: 13898.
23. Eagleson KL, Lane CJ, McFadyen-Ketchum L, Solak S, Wu HH, Levitt P. Distinct intracellular signaling mediates c-met regulation of dendritic growth and synaptogenesis. Dev Neurobiol 2016; 76: 1160-81.
24. Salian-Mehta S, Xu M, Wierman ME. Axl and met crosstalk to promote gonadotropin releasing hormone (gnrh) neuronal cell migration and survival. Mol Cell Endocrinol 2013; 374: 92-100.
25. Chen YY, Yu YN, Zhang YY, et al. Quantitative determination of flexible pharmacological mechanisms based on topological variation in mice anti-ischemic modular networks. PLoS One 2016; 11: e0158379.
26. Li B, Wang Y, Gu H, et al. Modular screening reveals driver induced additive mechanisms of baicalin and jasminoidin on cerebral ischemia therapy. Front Cardiovasc Med 2022; 9: 813983.
Outlines

/